Diagnosis of Ewing's Sarcoma and Related Tumours by Detection of Chromosome 22q12 Translocations Using Fluorescence in Situ Hybridization on Tumour Touch Imprints
Affiliations
It is increasingly recognized that the identification of t(11;22)(q24;q12) is a useful aid in the accurate diagnosis of Ewing's sarcoma and related tumours. However, cytogenetic studies have a low success rate and adequate tumour is not always available. This study describes the use of fluorescence in situ hybridization (FISH) to detect translocations at 22q12, the site of the EWS gene involved in t(11;22)(q24;q12), on tumour touch imprints made from true cut core-needle biopsy and frozen tumour. Of the seven tumours analysed, five diagnosed as Ewing's sarcoma or primitive neuroectodermal tumour demonstrated chromosome translocation at 22q12. This is a rapid and reliable method to detect a diagnostically relevant chromosome translocation using minimal amounts of fresh or frozen tumour.
Tumor Touch Imprints as Source for Whole Genome Analysis of Neuroblastoma Tumors.
Brunner C, Brunner-Herglotz B, Ziegler A, Frech C, Amann G, Ladenstein R PLoS One. 2016; 11(8):e0161369.
PMID: 27560999 PMC: 4999140. DOI: 10.1371/journal.pone.0161369.
Periosteal Ewing's Sarcoma: Report of Two New Cases and Review of the Literature.
Kollender Y, Shabat S, Nirkin A, Issakov J, Flusser G, Merimsky O Sarcoma. 2008; 3(2):85-8.
PMID: 18521268 PMC: 2395413. DOI: 10.1080/13577149977695.
Yamaguchi U, Hasegawa T, Morimoto Y, Tateishi U, Nakatani F, Kawai A J Clin Pathol. 2005; 58(10):1051-6.
PMID: 16189150 PMC: 1770737. DOI: 10.1136/jcp.2004.025502.
Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities.
Burchill S J Clin Pathol. 2003; 56(2):96-102.
PMID: 12560386 PMC: 1769883. DOI: 10.1136/jcp.56.2.96.
Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays.
Sotiriou C, Khanna C, Jazaeri A, Petersen D, Liu E J Mol Diagn. 2002; 4(1):30-6.
PMID: 11826185 PMC: 1906976. DOI: 10.1016/S1525-1578(10)60677-0.